A critical analysis and review of Lancet COVID-19 hydroxychloroquine study
Purpose A international registry analysis led by Mehra et al. to investigate the use of hydroxychloroquine (HCQ) and chloroquine (CQ) with or without a macrolide in 96,032 hospitalised COVID-19 patients were published on Lancet, which has raised considerable discussions in the public health communit...
Saved in:
| Main Authors: | Mondher Toumi, Malgorzata Biernikiewicz, Shuyao Liang, Yitong Wang, Tingting Qiu, Ru Han |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-01-01
|
| Series: | Journal of Market Access & Health Policy |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/20016689.2020.1809236 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The study of cardiotoxicity of hydroxychloroquine and azithromycine combination in hospitalized patients with COVID-19
by: Yu. N. Belenkov, et al.
Published: (2020-12-01) -
Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019
by: Pankaj Bansal, et al.
Published: (2021-01-01) -
Combined disease modifying treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine
by: N A Sergiets, et al.
Published: (2009-02-01) -
Hydroxychloroquine reduces metastatic tumor burden in pancreatic adenocarcinoma through myeloperoxidase inhibition
by: Britney Niemann, et al.
Published: (2025-08-01) -
Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study
by: Saja H. Almazrou, et al.
Published: (2020-12-01)